Mostrar el registro sencillo del ítem
dc.contributor.author | Esteve Moya, Vicent | es_ES |
dc.contributor.author | Celda,Bernardo | es_ES |
dc.contributor.author | Martínez-Bisbal, M.Carmen | es_ES |
dc.date.accessioned | 2016-03-22T15:14:21Z | |
dc.date.available | 2016-03-22T15:14:21Z | |
dc.date.issued | 2012-05-03 | |
dc.identifier.issn | 1618-2642 | |
dc.identifier.uri | http://hdl.handle.net/10251/62018 | |
dc.description.abstract | [EN] Quantitative multinuclear high-resolution magic angle spinning (HRMAS) was performed in order to determine the tissue pH values of and the absolute metabolite concentrations in 33 samples of human brain tumour tissue. Metabolite concentrations were quantified by 1D 1 H and 31P HRMAS using the electronic reference to in vivo concentrations (ERETIC) synthetic signal. 1 H–1 H homonuclear and 1 H–31P heteronuclear correlation experiments enabled the direct assessment of the 1 H–31P spin systems for signals that suffered from overlapping in the 1D 1 H spectra, and linked the information present in the 1D 1 H and 31P spectra. Afterwards, the main histological features were determined, and high heterogeneity in the tumour content, necrotic content and nonaffected tissue content was observed. The metabolite profiles obtained by HRMAS showed characteristics typical of tumour tissues: rather low levels of energetic molecules and increased concentrations of protective metabolites. Nevertheless, these characteristics were more strongly correlated with the total amount of living tissue than with the tumour cell contents of the samples alone, which could indicate that the sampling conditions make a significant contribution aside from the effect of tumour development in vivo. The use of methylene diphosphonic acid as a chemical shift and concentration reference for the 31P HRMAS spectra of tissues presented important drawbacks due to its interaction with the tissue. Moreover, the pH data obtained from 31P HRMAS enabled us to establish a correlation between the pH and the distance between the N(CH3)3 signals of phosphocholine and choline in 1 H spectra of the tissue in these tumour samples. | es_ES |
dc.description.sponsorship | The authors acknowledge the SCSIE-University of Valencia Microscopy Service for the histological preparations. They also acknowledge Martial Piotto (Bruker BioSpin, France) for providing the ERETIC synthetic signal. Furthermore, they acknowledge financial support from the Spanish Government project SAF2007-6547, the Generalitat Valenciana project GVACOMP2009-303, and the E.U.'s VI Framework Programme via the project "Web accessible MR decision support system for brain tumor diagnosis and prognosis, incorporating in vivo and ex vivo genomic and metabolomic data" (FP6-2002-LSH 503094). CIBER-BBN is an initiative funded by the VI National R&D&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions, and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund. | |
dc.language | Inglés | es_ES |
dc.publisher | Springer Verlag (Germany) | es_ES |
dc.relation.ispartof | Analytical and Bioanalytical Chemistry | es_ES |
dc.rights | Reserva de todos los derechos | es_ES |
dc.subject | 1 H and 31P spectroscopy | es_ES |
dc.subject | Human tumour biopsies | es_ES |
dc.subject | Metabolite concentration quantification | es_ES |
dc.title | Use of 1H and 31P HRMAS to evaluate the relationship between quantitative alterations in metabolite concentrations and tissue features in human brain tumour biopsies | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.doi | 10.1007/s00216-012-6001-z | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP6/503094/EU/WEB ACCESSIBLE MR DECISION SUPPORT SYSTEM FOR BRAIN TUMOUR DIAGNOSIS AND PROGNOSIS, INCORPORATING IN VIVO AND EX VIVO GENOMIC AND METABOLIMIC DATA/ETUMOUR/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/MEC//SAF2007-65473/ES/BIOMARCADORES MEDIANTE ANALISIS COMBINADO TRANSCRIPTOMICA, PROTEOMICA Y METABOLOMICA. APLICACION AL DIAGNOSTICO, PRONOSTICO Y SELECCION DE TRATAMIENTO EN NEOPLASIAS DE CEREBRO Y MAMA/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/GVA//ACOM%2FP2009%2F303/ | es_ES |
dc.rights.accessRights | Abierto | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Instituto de Reconocimiento Molecular y Desarrollo Tecnológico - Institut de Reconeixement Molecular i Desenvolupament Tecnològic | es_ES |
dc.description.bibliographicCitation | Esteve Moya, V.; Celda, B.; Martínez Bisbal, MC. (2012). Use of 1H and 31P HRMAS to evaluate the relationship between quantitative alterations in metabolite concentrations and tissue features in human brain tumour biopsies. Analytical and Bioanalytical Chemistry. 403:2611-2625. https://doi.org/10.1007/s00216-012-6001-z | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1007/s00216-012-6001-z | es_ES |
dc.description.upvformatpinicio | 2611 | es_ES |
dc.description.upvformatpfin | 2625 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 403 | es_ES |
dc.relation.senia | 274528 | es_ES |
dc.identifier.pmid | 22552786 | |
dc.contributor.funder | Ministerio de Educación y Ciencia | |
dc.contributor.funder | Generalitat Valenciana | |
dc.contributor.funder | European Commission | |
dc.description.references | Cheng LL, Chang IW, Louis DN, Gonzalez RG (1998) Cancer Res 58:1825–1832 | es_ES |
dc.description.references | Opstad KS, Bell BA, Griffiths JR, Howe FA (2008) Magn Reson Med 60:1237–1242 | es_ES |
dc.description.references | Sjobakk TE, Johansen R, Bathen TF, Sonnewald U, Juul R, Torp SH, Lundgren S, Gribbestad IS (2008) NMR Biomed 21:175–185 | es_ES |
dc.description.references | Martinez-Bisbal MC, Marti-Bonmati L, Piquer J, Revert A, Ferrer P, Llacer JL, Piotto M, Assemat O, Celda B (2004) NMR Biomed 17:191–205 | es_ES |
dc.description.references | Erb G, Elbayed K, Piotto M, Raya J, Neuville A, Mohr M, Maitrot D, Kehrli P, Namer IJ (2008) Magn Reson Med 59:959–965 | es_ES |
dc.description.references | Wilson M, Davies NP, Brundler MA, McConville C, Grundy RG, Peet AC (2009) Mol Cancer 8:6 | es_ES |
dc.description.references | Martinez-Bisbal MC, Monleon D, Assemat O, Piotto M, Piquer J, Llacer JL, Celda B (2009) NMR Biomed 22:199–206 | es_ES |
dc.description.references | Martínez-Granados B, Monleón D, Martínez-Bisbal MC, Rodrigo JM, del Olmo J, Lluch P, Ferrández A, Martí-Bonmatí L, Celda B (2006) NMR Biomed 19:90–100 | es_ES |
dc.description.references | Hubesch B, Sappey-Marinier D, Roth K, Meyerhoff DJ, Matson GB, Weiner MW (1990) Radiology 174:401–409 | es_ES |
dc.description.references | Albers MJ, Krieger MD, Gonzalez-Gomez I, Gilles FH, McComb JG, Nelson MD Jr, Bluml S (2005) Magn Reson Med 53:22–29 | es_ES |
dc.description.references | Wijnen JP, Scheenen TW, Klomp DW, Heerschap A (2010) NMR Biomed 23:968–976 | es_ES |
dc.description.references | Podo F (1999) NMR Biomed 12:413–439 | es_ES |
dc.description.references | Griffiths JR, Cady E, Edwards RH, McCready VR, Wilkie DR, Wiltshaw E (1983) Lancet 1:1435–1436 | es_ES |
dc.description.references | Robitaille PL, Robitaille PA, Gordon Brown G, Brown GG (1991) J Magn Reson 92:73–84, 1969 | es_ES |
dc.description.references | Griffiths JR (1991) Br J Cancer 64:425–427 | es_ES |
dc.description.references | Payne GS, Troy H, Vaidya SJ, Griffiths JR, Leach MO, Chung YL (2006) NMR Biomed 19:593–598 | es_ES |
dc.description.references | De Silva SS, Payne GS, Thomas V, Carter PG, Ind TE, deSouza NM (2009) NMR Biomed 22:191–198 | es_ES |
dc.description.references | Wang Y, Cloarec O, Tang H, Lindon JC, Holmes E, Kochhar S, Nicholson JK (2008) Anal Chem 80:1058–1066 | es_ES |
dc.description.references | Lehnhardt FG, Rohn G, Ernestus RI, Grune M, Hoehn M (2001) NMR Biomed 14:307–317 | es_ES |
dc.description.references | Srivastava NK, Pradhan S, Gowda GA, Kumar R (2010) NMR Biomed 23:113–122 | es_ES |
dc.description.references | Akoka S, Barantin L, Trierweiler M (1999) Anal Chem 71:2554–2557 | es_ES |
dc.description.references | Albers MJ, Butler TN, Rahwa I, Bao N, Keshari KR, Swanson MG, Kurhanewicz J (2009) Magn Reson Med 61:525–532 | es_ES |
dc.description.references | Ben Sellem D, Elbayed K, Neuville A, Moussallieh FM, Lang-Averous G, Piotto M, Bellocq JP, Namer IJ (2011) J Oncol 2011:174019 | es_ES |
dc.description.references | Bourne R, Dzendrowskyj T, Mountford C (2003) NMR Biomed 16:96–101 | es_ES |
dc.description.references | Martinez-Bisbal MC, Esteve V, Martinez-Granados B, Celda B (2011) J Biomed Biotechnol 2011:763684, Epub 2010 Sep 5 | es_ES |
dc.description.references | Celda B, Montelione GT (1993) J Magn Reson B 101:189–193 | es_ES |
dc.description.references | Esteve V, Celda B (2008) Magn Reson Mater Phys MAGMA 21:484–484 | es_ES |
dc.description.references | Collins TJ (2007) Biotechniques 43:25–30 | es_ES |
dc.description.references | Govindaraju V, Young K, Maudsley AA (2000) NMR Biomed 13:129–153 | es_ES |
dc.description.references | Fan TW-M (1996) Prog Nucl Magn Reson Spectrosc 28:161–219 | es_ES |
dc.description.references | Ulrich EL, Akutsu H, Doreleijers JF, Harano Y, Ioannidis YE, Lin J, Livny M, Mading S, Maziuk D, Miller Z, Nakatani E, Schulte CF, Tolmie DE, Kent Wenger R, Yao H, Markley JL (2008) Nucleic Acids Res 36:D402–D408 | es_ES |
dc.description.references | Kriat M, Vion-Dury J, Confort-Gouny S, Favre R, Viout P, Sciaky M, Sari H, Cozzone PJ (1993) J Lipid Res 34:1009–1019 | es_ES |
dc.description.references | Subramanian A, Shankar Joshi B, Roy AD, Roy R, Gupta V, Dang RS (2008) NMR Biomed 21:272–288 | es_ES |
dc.description.references | Daykin CA, Corcoran O, Hansen SH, Bjornsdottir I, Cornett C, Connor SC, Lindon JC, Nicholson JK (2001) Anal Chem 73:1084–1090 | es_ES |
dc.description.references | Griffin JL, Lehtimaki KK, Valonen PK, Grohn OH, Kettunen MI, Yla-Herttuala S, Pitkanen A, Nicholson JK, Kauppinen RA (2003) Cancer Res 63:3195–3201 | es_ES |
dc.description.references | Petroff OAC, Prichard JW (1995) In: Kraicer J, Dixon SJ (eds) Methods in neurosciences. Academic, San Diego | es_ES |
dc.description.references | Barton S, Howe F, Tomlins A, Cudlip S, Nicholson J, Anthony Bell B, Griffiths J (1999) Magn Reson Mater Phys Biol Med 8:121–128 | es_ES |
dc.description.references | Sitter B, Sonnewald U, Spraul M, Fjosne HE, Gribbestad IS (2002) NMR Biomed 15:327–337 | es_ES |
dc.description.references | Coen M, Hong YS, Cloarec O, Rhode CM, Reily MD, Robertson DG, Holmes E, Lindon JC, Nicholson JK (2007) Anal Chem 79:8956–8966 | es_ES |
dc.description.references | Russell D, Rubinstein LJ (1998) Russel and Rubinstein's pathology of tumors of the nervous system. Arnold, London | es_ES |
dc.description.references | Tynkkynen T, Tiainen M, Soininen P, Laatikainen R (2009) Anal Chim Acta 648:105–112 | es_ES |
dc.description.references | Kjaergaard M, Brander S, Poulsen F (2011) J Biomol NMR 49:139–149 | es_ES |
dc.description.references | Robert O, Sabatier J, Desoubzdanne D, Lalande J, Balayssac S, Gilard V, Martino R, Malet-Martino M (2011) Anal Bioanal Chem 399:987–999 | es_ES |
dc.description.references | Chadzynski GL, Bender B, Groeger A, Erb M, Klose U (2011) J Magn Reson 212:55–63 | es_ES |
dc.description.references | Weljie AM, Jirik FR (2011) Int J Biochem Cell Biol 43:981–989 | es_ES |
dc.description.references | Barba I, Cabanas ME, Arus C (1999) Cancer Res 59:1861–1868 | es_ES |
dc.description.references | Liimatainen T, Hakumaki JM, Kauppinen RA, Ala-Korpela M (2009) NMR Biomed 22:272–279 | es_ES |
dc.description.references | Opstad KS, Bell BA, Griffiths JR, Howe FA (2008) NMR Biomed 21:677–685 | es_ES |
dc.description.references | Schmitz JE, Kettunen MI, Hu D, Brindle KM (2005) Magn Reson Med 54:43–50 | es_ES |
dc.description.references | Glunde K, Artemov D, Penet MF, Jacobs MA, Bhujwalla ZM (2010) Chem Rev 110:3043–3059 | es_ES |
dc.description.references | Hertz L (2008) Neuropharmacology 55:289–309 | es_ES |
dc.description.references | Takahashi T, Otsuguro K, Ohta T, Ito S (2010) Br J Pharmacol 161:1806–1816 | es_ES |